Psilocybin-assisted Existential, Attachment and Relational (PEARL) Therapy for Caregivers of Patients With Advanced Cancer: A Phase II Open-Label Trial
Phase: PHASE2 | Sponsor: University Health Network, Toronto | Compound: Psilocybin
- Status
- recruiting
- Institution
- University Health Network, Toronto
- Start date
- 2025-07-02
- End date
- 2027-12-02
- Registry ID
- NCT07048743
Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.